TFDA-2024-0051-V451

Major variation for application TFDA-2024-0051. Major variation: Container Closure Change for Kcluximab — minor update

Variation Number
TFDA-2024-0051-V451
Type
Major
Application
TFDA-2024-0051
Change
CHG-2022-0151
Status
Failed
Fee
€14,090
Submitted
2023-11-28
Approved
—
Description

Major variation: Container Closure Change for Kcluximab — minor update